MX2009009996A - Composicion y metodo para tratar diabetes y trastornos metabolicos. - Google Patents
Composicion y metodo para tratar diabetes y trastornos metabolicos.Info
- Publication number
- MX2009009996A MX2009009996A MX2009009996A MX2009009996A MX2009009996A MX 2009009996 A MX2009009996 A MX 2009009996A MX 2009009996 A MX2009009996 A MX 2009009996A MX 2009009996 A MX2009009996 A MX 2009009996A MX 2009009996 A MX2009009996 A MX 2009009996A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- metabolic disorders
- treat diabetes
- diabetes
- subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89548607P | 2007-03-19 | 2007-03-19 | |
| PCT/US2008/056474 WO2008115723A1 (en) | 2007-03-19 | 2008-03-11 | Composition for treating diabetes and metabolic disorders with quercetin, myrcetin and chlorogenic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009009996A true MX2009009996A (es) | 2010-01-20 |
Family
ID=39590291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009009996A MX2009009996A (es) | 2007-03-19 | 2008-03-11 | Composicion y metodo para tratar diabetes y trastornos metabolicos. |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7943164B2 (enExample) |
| EP (1) | EP2129371B1 (enExample) |
| JP (1) | JP2010522185A (enExample) |
| CN (1) | CN101674821B (enExample) |
| BR (1) | BRPI0809047B8 (enExample) |
| CA (1) | CA2685031A1 (enExample) |
| MX (1) | MX2009009996A (enExample) |
| WO (1) | WO2008115723A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010522185A (ja) * | 2007-03-19 | 2010-07-01 | エーティーエム メタボリックス エルエルエルピー | 糖尿病および代謝障害を治療するためのクエルセチン、ミリセチンおよびクロロゲン酸の組成物 |
| JP5524466B2 (ja) * | 2008-10-31 | 2014-06-18 | ユニテックフーズ株式会社 | 中性風味デザートベース |
| US9918489B2 (en) * | 2008-12-17 | 2018-03-20 | Mark Gorris | Food-based supplement delivery system |
| US20100178413A1 (en) * | 2008-12-17 | 2010-07-15 | Mark Gorris | Food-based Supplement Delivery System |
| JP2011001311A (ja) * | 2009-06-19 | 2011-01-06 | Pola Chemical Industries Inc | 熱産生タンパク質発現促進剤 |
| RU2496331C1 (ru) * | 2009-08-10 | 2013-10-27 | Стукли-Ван Кэмп, Инк. | Способ суспендирования флавоноида в напитке |
| US9693577B2 (en) | 2010-01-29 | 2017-07-04 | Abbott Laboratories | Method of preparing a nutritional powder comprising spray dried HMB |
| TWI527581B (zh) | 2010-01-29 | 2016-04-01 | 亞培公司 | 包含hmb的無菌包裝營養液 |
| CA2785528C (en) | 2010-01-29 | 2015-07-14 | Abbott Laboratories | Nutritional emulsions comprising calcium hmb |
| TWI526161B (zh) | 2010-06-10 | 2016-03-21 | 亞培公司 | 包含鈣hmb及可溶性蛋白質之實質上透明營養液 |
| US8372447B2 (en) * | 2010-08-03 | 2013-02-12 | Northern Innovations And Formulations Corp. | Compositions and methods for promoting weight loss and increasing energy |
| WO2012097064A1 (en) * | 2011-01-13 | 2012-07-19 | Abbott Laboratories | Nutritional compositions and methods for controlling blood glucose |
| WO2012114204A2 (en) * | 2011-02-15 | 2012-08-30 | Ecole Polytechnique Federale De Lausanne (Epfl) Epfl-Tto | Methods of treating mitochondrial dysfunction |
| CA2835753C (en) * | 2011-06-06 | 2020-03-10 | Unilever Plc | An edible composition comprising a flavonoid aglycone and a flavonoid monoglucoside |
| JP2014521060A (ja) | 2011-06-28 | 2014-08-25 | コーニンクレッカ フィリップス エヌ ヴェ | 体液の検査用手段 |
| CN102772424B (zh) * | 2012-06-13 | 2014-01-08 | 浙江大学 | 新橙皮苷在制备防治糖尿病药物中的应用 |
| KR101396059B1 (ko) * | 2012-06-25 | 2014-05-16 | 중앙대학교 산학협력단 | 소귀나무잎으로부터 분리된 신규 황산염 페놀성 화합물 및 이의 항산화 및 항염 용도 |
| EP2867663B1 (en) | 2012-06-29 | 2022-12-07 | Koninklijke Philips N.V. | Processing of bound and unbound magnetic particles |
| WO2014001985A1 (en) | 2012-06-29 | 2014-01-03 | Koninklijke Philips N.V. | Processing of fluids containing interfering particles |
| CN104471374B (zh) | 2012-07-18 | 2019-05-21 | 皇家飞利浦有限公司 | 对具有目标成分的样本流体进行处理 |
| WO2014083474A1 (en) | 2012-11-30 | 2014-06-05 | Koninklijke Philips N.V. | Capture particle for selectively binding a target molecule |
| AU2015248506B2 (en) | 2014-04-13 | 2020-09-03 | Marmar Investment Sp. Z O.O. | Dietary compositions for reducing blood glucose levels and for weight management |
| EP3161485B1 (en) | 2014-06-25 | 2018-10-31 | Koninklijke Philips N.V. | Biosensor for the detection of target components in a sample |
| WO2016088029A1 (en) * | 2014-12-01 | 2016-06-09 | Cape Kingdom Nutraceuticals (Pty) Ltd | Therapeutic compositions |
| EP3274714B1 (en) | 2015-03-26 | 2019-07-03 | Koninklijke Philips N.V. | Manufacturing of a biosensor cartridge |
| CN105816473B (zh) * | 2015-07-06 | 2018-04-10 | 武汉华纳联合药业有限公司 | 一种黄酮苷类组合物及其制剂和制法 |
| JP2017105745A (ja) * | 2015-12-02 | 2017-06-15 | 共栄化学工業株式会社 | 皮膚外用剤 |
| US20180133243A1 (en) * | 2016-11-16 | 2018-05-17 | Holista Colltech Ltd | Method and composition for crude formulations of fortified sugar for glycemic control |
| TWI667036B (zh) | 2017-04-03 | 2019-08-01 | 大江生醫股份有限公司 | 植物萃取物於調控pdgfc、fgf2、igf1r、ptgis、nos3、edn1、plat、proc、vwf、f3、serpine1、il-8、icam1、vcam1及casp8基因的用途 |
| US20220257561A1 (en) * | 2019-06-07 | 2022-08-18 | Advanced Delivery Labs Llc | Compositions and methods for improving wellness |
| CN111387504A (zh) * | 2020-04-15 | 2020-07-10 | 武汉森澜生物科技有限公司 | 一种含绿原酸和柚皮苷的活性提取物、提取方法及其用途 |
| CN119255715A (zh) * | 2022-03-28 | 2025-01-03 | 路易斯安娜州立大学监测委员会,农业和机械学院 | 用于提高胰岛素敏感性的协同作用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3134233B2 (ja) | 1991-07-26 | 2001-02-13 | 株式会社林原生物化学研究所 | α−グリコシル ケルセチンとその製造方法並びに用途 |
| EP0969743B1 (en) * | 1997-03-20 | 2004-09-15 | Coventry Group, Ltd. | Nutritional supplement for cardiovascular health |
| US7229651B2 (en) | 1997-08-06 | 2007-06-12 | Melaleuca, Inc. | Dietary supplements containing natural ingredients |
| KR20000019716A (ko) | 1998-09-15 | 2000-04-15 | 박호군 | 바이오플라보노이드 화합물을 포함하는 혈당 강하용 조성물 |
| US20020068704A1 (en) | 1999-04-05 | 2002-06-06 | Ziegler Randy H. | Compositions and methods for treatment of diabetes |
| CA2405348A1 (en) | 2000-04-13 | 2001-11-01 | Ocean Spray Cranberries, Inc. | Novel compositions derived from cranberry and grapefruit and therapeutic uses therefor |
| US20030108627A1 (en) * | 2001-09-25 | 2003-06-12 | Jonathan Selzer | Cranberry based dietary supplement and dental hygiene product |
| US20030133945A1 (en) * | 2002-01-11 | 2003-07-17 | Farley Michael Donald | Natural food supplement |
| AU2003261903A1 (en) * | 2002-11-06 | 2004-06-07 | Kao Corporation | Blood fluidity improving agent |
| US7270837B2 (en) | 2003-11-10 | 2007-09-18 | Rutgers, The State University Of New Jersey | Anti-inflammatory cranberry flavonol extract preparations |
| US8017634B2 (en) | 2003-12-29 | 2011-09-13 | President And Fellows Of Harvard College | Compositions for treating obesity and insulin resistance disorders |
| WO2006024545A1 (en) | 2004-09-03 | 2006-03-09 | Stichting Voor De Technische Wetenschappen | Fused bicyclic natural compounds and their use as inhibitors of parp and parp-mediated inflammatory processes |
| US20060188590A1 (en) | 2005-01-05 | 2006-08-24 | Mitsunori Ono | Compositions for treating diabetes or obesity |
| US20070092454A1 (en) | 2005-10-24 | 2007-04-26 | Colgate-Palmolive Company | Oral composition containing morin |
| JP2010522185A (ja) * | 2007-03-19 | 2010-07-01 | エーティーエム メタボリックス エルエルエルピー | 糖尿病および代謝障害を治療するためのクエルセチン、ミリセチンおよびクロロゲン酸の組成物 |
-
2008
- 2008-03-11 JP JP2009554635A patent/JP2010522185A/ja active Pending
- 2008-03-11 BR BRPI0809047A patent/BRPI0809047B8/pt not_active IP Right Cessation
- 2008-03-11 US US12/045,852 patent/US7943164B2/en active Active
- 2008-03-11 WO PCT/US2008/056474 patent/WO2008115723A1/en not_active Ceased
- 2008-03-11 CA CA002685031A patent/CA2685031A1/en not_active Abandoned
- 2008-03-11 EP EP08731870.5A patent/EP2129371B1/en active Active
- 2008-03-11 MX MX2009009996A patent/MX2009009996A/es active IP Right Grant
- 2008-03-11 CN CN200880014120XA patent/CN101674821B/zh not_active Expired - Fee Related
-
2011
- 2011-01-27 US US13/014,798 patent/US8198319B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0809047B1 (pt) | 2020-09-01 |
| JP2010522185A (ja) | 2010-07-01 |
| WO2008115723A1 (en) | 2008-09-25 |
| US20110118345A1 (en) | 2011-05-19 |
| EP2129371B1 (en) | 2021-05-05 |
| CA2685031A1 (en) | 2008-09-25 |
| US8198319B2 (en) | 2012-06-12 |
| BRPI0809047B8 (pt) | 2021-05-25 |
| EP2129371A1 (en) | 2009-12-09 |
| CN101674821B (zh) | 2013-06-26 |
| BRPI0809047A2 (pt) | 2014-09-02 |
| US7943164B2 (en) | 2011-05-17 |
| US20080234364A1 (en) | 2008-09-25 |
| CN101674821A (zh) | 2010-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009009996A (es) | Composicion y metodo para tratar diabetes y trastornos metabolicos. | |
| CL2010001526A1 (es) | Compuestos derivados de isonicotinamida, moduladores de la estearoil-coa-desaturasa; composicion farmaceutica que comprende un compuesto;utiles para tratar enfermedades relacionadas con dislipidemia y trastornos del metabolismo de lipidos. | |
| MX2013010343A (es) | Composicion y metodos para el transplante de microbiota de colon. | |
| ECSP10010015A (es) | Inhibidores de proteasoma | |
| MX386489B (es) | Inhibidores de ibat para el tratamiento de enfermedades hepaticas. | |
| BR112013009142A2 (pt) | "composição modeladora de fibra queratinosa, kit modelador de fibra queratinosa e métod para tratamento de uma fibra queratinosa" | |
| ECSP088904A (es) | Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina | |
| GB0920703D0 (en) | Compositions containing satiogens and methods of use | |
| BRPI0920670A8 (pt) | composição nutritiva para promover o desenvolvimento e crescimento sadios | |
| BR112012023021A2 (pt) | compostos de indazol e seus usos | |
| BR112013024025A8 (pt) | Composição fluida destinada a ser aplicada na pele | |
| UY34950A (es) | Composición y método adecuado para enfermedades provocadas por fitopatógenos y método para proteger sustancias naturales de origen animal y/o vegetal | |
| ECSP11011411A (es) | Derivados de prolina como inhibidores de catepsina | |
| MX2011006006A (es) | Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos. | |
| BRPI0815821A2 (pt) | Composições e métodos que empregam antagonistas nmda para alcançar um efeito poupador de anestésico. | |
| BRPI0924653B8 (pt) | composto de ferro-oligossacarídeo, composição e uso de deste composto | |
| BRPI0818007A2 (pt) | composição para regular o metabolismo lipídico | |
| CL2012001961A1 (es) | Método para tratar una enfermedad o trastorno en que aumentan los niveles de hormonas de estrés y/o disminuyen los niveles de hormonas de andrógenos, en que se administra un compuesto pirrolo-[1,2-c]-imidazol-bencil sustituido; su uso en insuficiencia cardíaca, entre otros; y compuestos pirrolo-[1,2-c]-imidazol-bencil sustituidos. | |
| MX360554B (es) | Composiciones que comprenden y metodos que utilizan inhibidores de co-transportadores de glucosa-sodio 1 y 2. | |
| BR112012018843A2 (pt) | radioimunoconjugado que se liga a cd37humano composição farmacêutica uso do radioimunoconjugado metodo para tratamento de uma malignidade de célula b e kit para a produçãoradioimunoconjugado | |
| EP2063881A4 (en) | COMPOSITION AND METHOD FOR THE EFFECTIVE AND SAFE ADMINISTRATION OF HALOPYRUVATE FOR THE TREATMENT OF CANCER | |
| BRPI1014362A2 (pt) | método e composição para sincronizar o tempo de inseminação | |
| BRPI0905995A2 (pt) | "composição conservante para ser adicionada a um produto formulado, produto a ser conservado, método de fabricação do produto e uso de uma composição" | |
| BRPI0910575A2 (pt) | métodos para tratar degeneração macular relacionada com a idade, para limitar desenvolvimento de degeneração macular relacionada com a idade, e para identificar compostos para tratar degeneração macular relacionada com a idade, e, composição | |
| CL2009001139A1 (es) | Composicion que comprende un lisofosfolipido para tratar los efectos de la inflamacion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |